Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2

The development of mRNA vaccines represented a significant achievement in response to the global health crisis during the SARS-CoV-2 pandemic. Evaluating vaccine efficacy entails identifying different anti-SARS-CoV-2 antibodies, such as total antibodies against the Receptor Binding Domain (RBD) of t...

Description complète

Détails bibliographiques

Auteurs principaux:	Roberto Alonso, Sergio Gil-Manso, Pilar Catalán, Ignacio Sánchez-Arcilla, Marco Marzola, Rafael Correa-Rocha, Patricia Muñoz, Marjorie Pion, the Gregorio Marañón Microbiology-ID COVID-19 Study Group
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2024-02-01
Collection:	Frontiers in Immunology
Sujets:	SARS-CoV-2 anti-RBD IgG neutralizing antibodies breakthrough infection humoral immunity
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1341313/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!